Le Lézard
Classified in: Health
Subject: AWD

Recipients of 2018 CMA Awards celebrated in Winnipeg


WINNIPEG, Aug. 21, 2018 /CNW/ - Today, the Canadian Medical Association (CMA) presented its 2018 awards as part of its annual recognition of outstanding individuals who have made an exceptional contribution to medicine and the health care system.

"Taking a moment to highlight and recognize the work of these deserving individuals reminds us all of the incredible work being done every day in this country. It's my privilege to acknowledge these individuals for their exceptional work in health care," said Dr. Laurent Marcoux, CMA president.

The 2018 CMA Award recipients are:

For more information on award recipients, please visit https://www.cma.ca/En/Pages/cma-awards.aspx.

The Canadian Medical Association unites 85,000 physicians and physicians-in-training on national health and medical matters. Formed in Quebec City in 1867, the CMA's rich history of advocacy led to some of Canada's most important health policy changes. As we look to the future, the CMA will focus on advocating for a healthy population and a vibrant profession.

 

SOURCE Canadian Medical Association


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: